Fludarabine-induced apoptosis in CD4+ CD25+ and CD4+ CD25– T cells
. | Experiment 1 . | . | Experiment 2 . | . | ||
---|---|---|---|---|---|---|
. | Medium . | Medium plus fludarabine . | Medium . | Medium plus fludarabine . | ||
CD4+ CD25–, % | 91 | 66 | 90 | 52 | ||
CD4+ CD25+, % | 69 | 23 | 79 | 30 |
. | Experiment 1 . | . | Experiment 2 . | . | ||
---|---|---|---|---|---|---|
. | Medium . | Medium plus fludarabine . | Medium . | Medium plus fludarabine . | ||
CD4+ CD25–, % | 91 | 66 | 90 | 52 | ||
CD4+ CD25+, % | 69 | 23 | 79 | 30 |
CD4+ CD25+ T cells are more susceptible to fludarabine-induced apoptosis than CD4+ CD25– T cells. PBMCs from 2 different donors were incubated in vitro with medium alone or with medium containing 10 μM fludarabine. After 48 hours cells were stained with 7-AAD and annexin V and viable cells were defined as 7-AAD and annexin-V double-negative cells. Viable cells are listed as percentage of the respective cell type.